Leukocyte Redistribution: Effects of Beta Blockers in Patients with Chronic Heart Failure

• Stephan von Haehling ,

  * E-mail: stephan.von.haehling@web.de

  Affiliations Applied Cachexia Research, Dept. of Cardiology, Charité Medical School, Campus Virchow-Clinic, Berlin, Germany, Department of Clinical Cardiology, National Heart & Lung Institute, Imperial College School of Medicine, London, United Kingdom

  ⨯
• Joerg C. Schefold,

  Affiliation Department of Nephrology and Intensive Care Medicine, Charité Medical School, Campus Virchow Clinic, Berlin, Germany

  ⨯
• Ewa Jankowska,

  Affiliations Applied Cachexia Research, Dept. of Cardiology, Charité Medical School, Campus Virchow-Clinic, Berlin, Germany, Department of Cardiology, Military Hospital, Wroclaw, Poland

  ⨯
• Wolfram Doehner,

  Affiliation Applied Cachexia Research, Dept. of Cardiology, Charité Medical School, Campus Virchow-Clinic, Berlin, Germany

  ⨯
• Jochen Springer,

  Affiliation Applied Cachexia Research, Dept. of Cardiology, Charité Medical School, Campus Virchow-Clinic, Berlin, Germany

  ⨯
• Kristin Strohschein,

  Affiliation Department of Clinical Cardiology, National Heart & Lung Institute, Imperial College School of Medicine, London, United Kingdom

  ⨯
• Sabine Genth-Zotz,

  Affiliation Department of Medicine II, Johannes Gutenberg-University, Mainz, Germany

  ⨯
• Hans-Dieter Volk,

  Affiliation Department of Medical Immunology, Charité Medical School, Campus Mitte, Berlin, Germany

  ⨯
• Philip Poole-Wilson,

  Affiliation Department of Clinical Cardiology, National Heart & Lung Institute, Imperial College School of Medicine, London, United Kingdom

  ⨯
• Stefan D. Anker

  Affiliations Applied Cachexia Research, Dept. of Cardiology, Charité Medical School, Campus Virchow-Clinic, Berlin, Germany, Department of Clinical Cardiology, National Heart & Lung Institute, Imperial College School of Medicine, London, United Kingdom

  ⨯